Activity Overview

This educational activity is an archive of the live conference held on February 21, 2026.

Target Audience

This educational activity is directed toward medical oncologists, fellows, surgical oncologists, and radiation oncologists who treat patients with skin and other cutaneous malignancies. Dermatologists, dermatopathologists, pathologists, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in treating melanoma and other cutaneous malignancies will also be invited to participate.

Learning Objectives

Assess recent evidence from clinical trials focusing on current and emerging novel treatment approaches for melanoma and other skin tumor

Module 2: Novel Immunotherapies for Melanoma

GET STARTED WITH THIS PROGRAM:

Create Account Already Registered? Login Here

Accreditation/Credit Designation

Physicians’ Education Resource^®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource^®, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource^®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hour.

Acknowledgment of Commercial Support

This activity is supported by educational grants from Castle Biosciences, Inc; Immatics; Immunocore; and Obsidian Therapeutics.

Module 2: Novel Immunotherapies for Melanoma

GET STARTED WITH THIS PROGRAM:

Related Content